Sirtex Medical Limit
SRX
End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 04/26
27.77AUD
+0.07%
Prev.27.7500
Open27.7600
High27.8500
Low27.7600
Volume606 910
Last news
Financials
Sales 2018 232 M
EBIT 2018 74,9 M
R. net 2018 58,2 M
Tréso. 2018 112 M
Rend. 2018 1,06%
P/E ratio 2018 27,37
P/E ratio 2019 24,62
EV / Sales 2018 6,18x
EV / Sales 2019 5,65x
Capitalization 1 548 M
Company
Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments.It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres.Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC.
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2018-08-22 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance27,827,827,8
Spread/Res.-0,07%-0,07%0,04%
Spread/Supp.0,25%46%55%
Support27,719,117,9